coproporphyrin i has been researched along with Chronic Kidney Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chu, X; Galetin, A; Ogungbenro, K; Scotcher, D; Takita, H; Yee, KL | 1 |
Ando, T; Itoh, H; Mimata, H; Ohno, K; Ono, H; Sasamoto, Y; Shin, T; Suzuki, Y; Tanaka, R; Yoshijima, C | 1 |
2 other study(ies) available for coproporphyrin i and Chronic Kidney Diseases
Article | Year |
---|---|
Coproporphyrin I as an Endogenous Biomarker to Detect Reduced OATP1B Activity and Shift in Elimination Route in Chronic Kidney Disease.
Topics: Biomarkers; Coproporphyrins; Drug Interactions; Humans; Liver-Specific Organic Anion Transporter 1; Organic Anion Transporters; Prospective Studies; Renal Insufficiency, Chronic; Rifampin | 2022 |
Simultaneous quantification of coproporphyrin-I and 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid in human plasma using ultra-high performance liquid chromatography coupled to tandem mass spectrometry.
Topics: Adult; Aged; Chromatography, High Pressure Liquid; Coproporphyrins; Female; Furans; Humans; Liver-Specific Organic Anion Transporter 1; Male; Middle Aged; Plasma; Propionates; Renal Insufficiency, Chronic; Solid Phase Extraction; Tandem Mass Spectrometry; Young Adult | 2020 |